0
0
Read Time:9 Second
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 25, 2026, titled “Alembic Pharmaceuticals Limited receives USFDA Final Approval for Fingolimod Capsules 0.5 mg.”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %